Related Experiment Video
Updated: Jun 17, 2026

Retroperitoneal Laparoscopic Debridement and Drainage for Pancreatic Abscess
Published on: March 15, 2024
Treatment strategy for acute pancreatitis
Keita Wada1, Tadahiro Takada, Koichi Hirata
1Department of Surgery, Teikyo University School of Medicine, 2-11-1, Kaga-cho, Itabashi, Tokyo, 173, Japan. wada@med.teikyo-u.ac.jp
Immediate medical treatment for acute pancreatitis (AP) includes IV fluids, pain relief, and monitoring. Severity assessment guides treatment, with early intervention crucial for mild cases and intensive care for severe acute pancreatitis (SAP) to prevent complications.
Area of Science:
- Gastroenterology
- Critical Care Medicine
- Diagnostic Imaging
Background:
- Acute pancreatitis (AP) requires prompt medical intervention, including fluid resuscitation, analgesia, and vital sign monitoring.
- Severity assessment is critical for tailoring treatment and preventing complications, necessitating repeat evaluations due to the condition's instability.
Purpose of the Study:
- To outline the diagnostic and therapeutic strategies for acute pancreatitis, differentiating between mild and severe forms.
- To emphasize the importance of etiological investigation and timely interventions, such as ERCP/ES for biliary pancreatitis.
- To detail management approaches for both early and late stages of AP, including intensive care and management of infectious complications.
Main Methods:
- Initial management involves fasting, intravenous (IV) fluid replacement, analgesics, and vital sign monitoring.
- Severity is assessed using clinical signs, blood tests, urinalysis, and imaging.
- Etiology is investigated via blood tests, urinalysis, and diagnostic imaging.
- Endoscopic retrograde cholangiopancreatography with or without endoscopic sphincterotomy (ERCP/ES) is considered for biliary pancreatitis with cholangitis or stasis.
- Infectious complications are diagnosed using fine needle aspiration (FNA).
Main Results:
- Mild AP cases are managed with continued fundamental treatment until symptom resolution.
- Severe acute pancreatitis (SAP) requires referral to specialized centers for intensive care, focusing on hemodynamic stabilization, respiratory support, and antibiotics.
- Continuous hemodiafiltration (CHDF) and continuous regional arterial infusion (CRAI) may benefit early SAP.
- In late-stage AP, infectious complications are critical; FNA aids diagnosis.
- Treatment for infected pancreatic necrosis includes percutaneous, endoscopic, laparoscopic, or surgical approaches, with necrosectomy performed as late as possible.
- Pancreatic abscesses require drainage.
Conclusions:
- Prompt and accurate diagnosis, coupled with tailored treatment strategies based on severity and etiology, are essential for managing acute pancreatitis.
- Early and aggressive management of SAP, including intensive care and timely interventions for complications, improves outcomes.
- Distinguishing between sterile and infected necrosis guides therapeutic decisions, prioritizing less invasive methods when feasible and delaying necrosectomy when possible.
Related Concept Videos
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis I: Introduction
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Acute Pancreatitis II: Pathophysiology
